NL8103784A - Farmaceutische preparaten; bereidingsmethode. - Google Patents
Farmaceutische preparaten; bereidingsmethode. Download PDFInfo
- Publication number
- NL8103784A NL8103784A NL8103784A NL8103784A NL8103784A NL 8103784 A NL8103784 A NL 8103784A NL 8103784 A NL8103784 A NL 8103784A NL 8103784 A NL8103784 A NL 8103784A NL 8103784 A NL8103784 A NL 8103784A
- Authority
- NL
- Netherlands
- Prior art keywords
- cisplatin
- microcrystalline
- sterile
- concentration
- microcrystalline cisplatin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G55/00—Compounds of ruthenium, rhodium, palladium, osmium, iridium, or platinum
- C01G55/002—Compounds containing, besides ruthenium, rhodium, palladium, osmium, iridium, or platinum, two or more other elements, with the exception of oxygen or hydrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/74—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by peak-intensities or a ratio thereof only
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/51—Particles with a specific particle size distribution
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/61—Micrometer sized, i.e. from 1-100 micrometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/80—Compositional purity
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8130179 | 1979-10-02 | ||
US06/081,301 US4302446A (en) | 1979-10-02 | 1979-10-02 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
NL8103784A true NL8103784A (nl) | 1983-03-01 |
Family
ID=22163311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8103784A NL8103784A (nl) | 1979-10-02 | 1981-08-12 | Farmaceutische preparaten; bereidingsmethode. |
Country Status (12)
Country | Link |
---|---|
US (2) | US4302446A (da) |
JP (1) | JPS5832029A (da) |
AT (1) | AT375326B (da) |
AU (1) | AU551710B2 (da) |
BE (1) | BE890192A (da) |
CA (1) | CA1152289A (da) |
CH (1) | CH647216A5 (da) |
DE (1) | DE3133443A1 (da) |
FR (1) | FR2511357B1 (da) |
GB (1) | GB2103591B (da) |
NL (1) | NL8103784A (da) |
SE (2) | SE450830B (da) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1153974B (it) * | 1982-09-23 | 1987-01-21 | Erba Farmitalia | Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento |
DE3305248C2 (de) * | 1983-02-16 | 1987-04-09 | Degussa Ag, 6000 Frankfurt | Verfahren zur Reinigung von cis-Platin-(II)-diammin-dichlorid |
NL8303657A (nl) * | 1983-10-24 | 1985-05-17 | Pharmachemie Bv | Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan. |
US4699978A (en) * | 1985-01-18 | 1987-10-13 | The Trustees Of Columbia University In The City Of New York | Site-specific chiral ruthenium (II) and cobalt (III) antitumor agents |
US4686104A (en) * | 1985-04-30 | 1987-08-11 | Sloan-Kettering Institute For Cancer Research | Methods of treating bone disorders |
JPS61293655A (ja) * | 1985-05-31 | 1986-12-24 | Trinity Ind Corp | 砂型鋳造品の砂落し装置 |
CS269719B1 (en) * | 1986-12-29 | 1990-05-14 | Kiss Frantisek | Platinum cytostatic |
JP2657393B2 (ja) * | 1988-05-18 | 1997-09-24 | 日本化薬株式会社 | 化学塞栓療法剤 |
FI895340A0 (fi) * | 1988-11-14 | 1989-11-09 | Bristol Myers Squibb Co | Hypertonisk cisplatin-loesning. |
US4946689A (en) * | 1988-11-23 | 1990-08-07 | Bristol-Myers Company | Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin |
US8728536B2 (en) * | 1996-10-16 | 2014-05-20 | Etex Corporation | Chemotherapeutic composition using nanocrystalline calcium phosphate paste |
US6251355B1 (en) | 1996-12-25 | 2001-06-26 | Nippon Kayaku Kabushiki Kaisha | Fine cisplatin powder and process for the production thereof |
US6074626A (en) * | 1998-03-20 | 2000-06-13 | Molecular Radiation Management, Inc. | Radioactive cisplatin in the treatment of cancer |
WO2001024763A2 (en) | 1999-10-01 | 2001-04-12 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
AUPQ641100A0 (en) * | 2000-03-23 | 2000-04-15 | Australia Nuclear Science & Technology Organisation | Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents |
EP1473036B1 (en) | 2000-04-24 | 2006-08-09 | Teva Pharmaceutical Industries Ltd. | Zolpidem hemitartrate solvate |
DE60125429T2 (de) * | 2000-04-24 | 2007-09-27 | Teva Pharmaceutical Industries Ltd. | Zolpidem hemitartrat solvat |
GB0011903D0 (en) * | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
HUP0500642A2 (hu) * | 2001-09-24 | 2005-11-28 | Tosk, Inc. | Csökkentett toxicitású ciszplatin készítmények és eljárás alkalmazásukra |
DE602004028585D1 (de) * | 2003-03-15 | 2010-09-23 | Brin Tech Internat Ltd | Verpackung für Arzneimittel |
BRPI0408805A (pt) * | 2003-03-31 | 2006-03-28 | Pliva Lachema As | composição farmacêutica contendo complexo de platina e método de fabricação da mesma |
WO2005037821A2 (en) * | 2003-10-16 | 2005-04-28 | Teva Pharmaceutical Industries Ltd. | Preparation of candesartan cilexetil |
ATE387203T1 (de) * | 2004-01-05 | 2008-03-15 | Teva Pharma | Prozesse zur herstellung von sildenafil-base und zitratsalz |
EP1713795A2 (en) * | 2004-02-11 | 2006-10-25 | Teva Pharmaceutical Industries Ltd. | Candesartan cilexetil polymorphs |
US20080085882A1 (en) * | 2006-08-18 | 2008-04-10 | University Of North Texas Health Science Center At Fort Worth | Compositions and Methods for Potentiation of Cancer Agents |
US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8168661B2 (en) * | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8178564B2 (en) * | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8173686B2 (en) * | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US20110033528A1 (en) * | 2009-08-05 | 2011-02-10 | Poniard Pharmaceuticals, Inc. | Stabilized picoplatin oral dosage form |
AU2008214199A1 (en) * | 2007-02-09 | 2008-08-14 | Poniard Pharmaceuticals, Inc. | Encapsulated picoplatin |
TW200916094A (en) * | 2007-06-27 | 2009-04-16 | Poniard Pharmaceuticals Inc | Stabilized picoplatin dosage form |
US20100260832A1 (en) * | 2007-06-27 | 2010-10-14 | Poniard Pharmaceuticals, Inc. | Combination therapy for ovarian cancer |
CN101809024A (zh) * | 2007-07-16 | 2010-08-18 | 铂雅制药公司 | 吡铂的口服制剂 |
JP2011511071A (ja) * | 2008-02-08 | 2011-04-07 | ポニアード ファーマシューティカルズ, インコーポレイテッド | 肺癌を治療するためのピコプラチンおよびアムルビシン |
JP5667886B2 (ja) | 2008-03-14 | 2015-02-12 | バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド | 癌患者の生存時間を増大させるための組成物及び化合物の使用方法 |
CA2717181C (en) | 2008-03-14 | 2013-10-15 | Bionumerik Pharmaceuticals, Inc. | Treatment methods and compositions for lung cancer, adenocarcinoma, and other medical conditions |
US20100035853A1 (en) * | 2008-08-07 | 2010-02-11 | Hyogo College Of Medicine | Method for preventing or treating cisplatin-induced nephrotoxicity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4079121A (en) * | 1974-12-13 | 1978-03-14 | Mobil Oil Corporation | Complexes of beta platinum chloride and ammonia |
SE445172B (sv) * | 1978-05-30 | 1986-06-09 | Bristol Myers Co | Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform |
US4273755A (en) * | 1979-08-16 | 1981-06-16 | Mpd Technology Corporation | Preparation of platinum complexes |
-
1979
- 1979-10-02 US US06/081,301 patent/US4302446A/en not_active Expired - Lifetime
-
1980
- 1980-09-29 US US06/191,982 patent/US4322391A/en not_active Expired - Lifetime
-
1981
- 1981-08-03 SE SE8104661A patent/SE450830B/sv not_active IP Right Cessation
- 1981-08-04 GB GB08123759A patent/GB2103591B/en not_active Expired
- 1981-08-07 AU AU73906/81A patent/AU551710B2/en not_active Ceased
- 1981-08-12 JP JP56125390A patent/JPS5832029A/ja active Granted
- 1981-08-12 NL NL8103784A patent/NL8103784A/nl not_active Application Discontinuation
- 1981-08-14 FR FR8115760A patent/FR2511357B1/fr not_active Expired
- 1981-08-21 CA CA000384425A patent/CA1152289A/en not_active Expired
- 1981-08-24 DE DE19813133443 patent/DE3133443A1/de active Granted
- 1981-08-28 AT AT0374981A patent/AT375326B/de not_active IP Right Cessation
- 1981-09-02 BE BE0/205848A patent/BE890192A/fr not_active IP Right Cessation
- 1981-09-10 CH CH5865/81A patent/CH647216A5/de not_active IP Right Cessation
-
1983
- 1983-02-07 SE SE8300623A patent/SE455469B/sv not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AT375326B (de) | 1984-07-25 |
SE455469B (sv) | 1988-07-18 |
SE8300623L (sv) | 1983-02-07 |
US4302446A (en) | 1981-11-24 |
CA1152289A (en) | 1983-08-23 |
AU7390681A (en) | 1983-02-10 |
FR2511357A1 (fr) | 1983-02-18 |
SE8300623D0 (sv) | 1983-02-07 |
BE890192A (fr) | 1982-03-02 |
JPS5832029A (ja) | 1983-02-24 |
JPH0313174B2 (da) | 1991-02-21 |
SE8104661L (sv) | 1983-02-04 |
DE3133443A1 (de) | 1983-03-10 |
CH647216A5 (de) | 1985-01-15 |
ATA374981A (de) | 1983-12-15 |
GB2103591B (en) | 1985-03-06 |
FR2511357B1 (fr) | 1986-09-05 |
SE450830B (sv) | 1987-08-03 |
US4322391A (en) | 1982-03-30 |
GB2103591A (en) | 1983-02-23 |
AU551710B2 (en) | 1986-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL8103784A (nl) | Farmaceutische preparaten; bereidingsmethode. | |
US4748174A (en) | Water soluble salts of an NSAID with meglumine/glucamine | |
ES2257038T3 (es) | Metodos y composiciones para la administracion de taxanos. | |
CA2766291A1 (en) | Injectable formulations containing asenapine and method of treatment using same | |
DE3333024A1 (de) | Neue pharmakologische zusammensetzungen auf basis von cis-platin und verfahren zu deren herstellung | |
KR880002087B1 (ko) | 항균성 나프티리딘 또는 퀴놀린 화합물의 염 및 그의 제조방법 | |
CN102140079B (zh) | 新乌碱及其制备方法和以该化合物为活性成分的药物组合物及用途 | |
HUE030221T2 (en) | Solid pharmaceutical composition containing biopterin derivatives and uses of such compositions | |
CN102600070B (zh) | 环磷腺苷葡胺组合物注射液及其制备方法 | |
HU195728B (en) | Process for production of dry materials and suspensions containing thereof | |
DD142293A5 (de) | Verfahren zur herstellung eines pharmazeutischen mittels | |
HU183379B (en) | Process for producing stabil, concentrated cisplatine solutions | |
DE69627209T2 (de) | Lyophilisiertes thioxanthenon-antitumormedikament | |
EP0944612B1 (en) | N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate | |
FI72302C (fi) | Foerfarande foer framstaellning av stabilt mikrokristallint cisplatin. | |
CN103073617A (zh) | N(2)-l-丙氨酰-l-谷氨酰胺的化合物 | |
IE51468B1 (en) | Microcrystalline cisplatin and formulations containing it | |
CS269719B1 (en) | Platinum cytostatic | |
Levy et al. | DETERIORATION OF CRYSTALLINE STROPHANTHIN IN AQUEOUS SOLUTION: Its Relation to Hydrogen Ion Concentration and a Method for Its Prevention. | |
HU206627B (en) | Process for producing stabile aqouos solution of 8-n-/diethyl-amino-ethyl/-rebeccamycin | |
DK157484B (da) | Fremgangsmaade til fremstilling af et cisplatin-praeparat | |
US4946689A (en) | Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin | |
CZ8095A3 (en) | Hydrochloride of ng-monomethyl-l-arginine, process of its preparation, pharmaceutical composition containing thereof and its use in medicine | |
RU2216332C1 (ru) | Лечебный препарат для лечения артроза | |
EP1691813B1 (en) | Ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one, sterile, stable; closed system for packing the solution, process for eliminating alkaline residuals of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one crystals; |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A85 | Still pending on 85-01-01 | ||
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
DNT | Communications of changes of names of applicants whose applications have been laid open to public inspection |
Free format text: BRISTOL-MYERS SQUIBB COMPANY |
|
BV | The patent application has lapsed |